Three more updates to protect your gains

GE HEALTHCARE TECHNOLOGIES INC. $89 is a buy. The company (Nasdaq symbol GEHC; Conservative Growth Portfolio, Manufacturing sector; Shares outstanding: 456.7 million; Market cap: $40.6 billion; Price-to-sales ratio: 2.1; Dividend yield: 0.1%; TSINetwork Rating: Average; www.gehealthcare.com) makes X-ray equipment, MRIs and ultrasound scanners.
On January 3, 2023, General Electric… Read More

They’ve given you triple-digit gains

Agilent and Keysight are great examples of how spinoffs can deliver big returns for growth investors. In the 10 years since Agilent spun off Keysight (shareholders received one Keysight share for every two shares they held), the stock is up 220%, while Keysight has soared… Read More

Top banks will gain from rate cuts

As inflation eases in the wake of COVID-19 lockdowns and supply chain disruptions, the U.S. Federal Reserve recently cut its benchmark interest rate by 0.50%, to between 4.75% and 5.00%. It also looks likely that the Fed will continue to cut the rate in the… Read More

TD ready for growth after compliance woes

Note the following analysis was published just before announcement of TD’s settlement with U.S. banking regulators. Please see here for our update on the stock following that news. Note TD remains a buy.
TD Bank had to cancel its deal to acquire American banking firm First… Read More